ALV vs GAP

Autoliv (ALV) shows mixed financial health with a weak Piotroski F-Score of 4/9, indicating borderline stability, and no available Altman Z-Score to assess distress risk. The stock appears reasonably valued with a P/E of 13.03 below sector average, strong ROE of 31.01%, and solid earnings growth of 31% YoY, but faces concerns around liquidity (Current Ratio: 0.95) and technical weakness (Technical Trend: 10/100). Dividend strength is moderate at 50/100 with a sustainable 2.48% yield, while analyst consensus leans positive with a $138.72 target price. However, insider sentiment is lukewarm and recent price performance shows decelerating momentum despite solid long-term returns.

GAP exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9, indicating solid operational improvement despite a lack of Altman Z-Score data. However, the stock is currently trading at a premium to both its Graham Number ($22.13) and Intrinsic Value ($14.91), suggesting limited valuation upside. While the balance sheet is stable and the P/E ratio is low relative to the sector, significant headwinds include negative earnings growth (-16% YoY) and a starkly bearish insider sentiment. The disconnect between analyst 'Buy' ratings and the 0/100 technical trend suggests a high-risk environment for new entries.